These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16750716)

  • 1. Cardiac function and heart failure.
    Wagoner LE; Starling RC; O'Connor CM
    J Am Coll Cardiol; 2006 Jun; 47(11 Suppl):D18-22. PubMed ID: 16750716
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blockers in heart failure: potential of carvedilol.
    Fowler MB
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S62-7. PubMed ID: 8098065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure therapy in evolution.
    Chatterjee K
    Circulation; 1996 Dec; 94(11):2689-93. PubMed ID: 8941088
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of beta-blockade on chronic heart failure.
    Bloomenthal R
    J Fam Pract; 1996 Aug; 43(2):116-7. PubMed ID: 8708614
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET).
    Cleland JG; Charlesworth A; Lubsen J; Swedberg K; Remme WJ; Erhardt L; Di Lenarda A; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson PA;
    J Am Coll Cardiol; 2006 Apr; 47(8):1603-11. PubMed ID: 16630997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the journey.
    Stevenson LW; Lewis E
    J Am Coll Cardiol; 2006 Apr; 47(8):1612-4. PubMed ID: 16630998
    [No Abstract]   [Full Text] [Related]  

  • 7. Conivaptan Yamanouchi.
    Doggrell SA
    Curr Opin Investig Drugs; 2005 Mar; 6(3):317-26. PubMed ID: 15816509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecule of the Month: Conivaptan hydrochloride.
    Drug News Perspect; 2006 Nov; 19(9):574. PubMed ID: 17220962
    [No Abstract]   [Full Text] [Related]  

  • 9. Top heart failure drugs compared.
    Health News; 2003 Sep; 9(9):6-7. PubMed ID: 14584471
    [No Abstract]   [Full Text] [Related]  

  • 10. Using carvedilol to treat heart failure.
    Taccetta-Chapnick M
    Crit Care Nurse; 2002 Apr; 22(2):36-40, 42-6, 48 passim. PubMed ID: 11961943
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disorders of body water regulation and the therapy using diuretics].
    Orita Y; Nakahama H
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1660-4. PubMed ID: 9410979
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
    Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
    Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyponatraemia, antagonists of the antidiuretic hormone and cardiac failure].
    de Groote P
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):215-20. PubMed ID: 16618024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Association for the Advancement of Science meeting. DNA tells story of heart drug failure.
    Couzin J
    Science; 2005 Feb; 307(5713):1191. PubMed ID: 15731420
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.
    Miyazaki T; Fujiki H; Yamamura Y; Nakamura S; Mori T
    Cardiovasc Drug Rev; 2007; 25(1):1-13. PubMed ID: 17445084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction.
    Takeda Y; Fukutomi T; Suzuki S; Yamamoto K; Ogata M; Kondo H; Sugiura M; Shigeyama J; Itoh M
    Am J Cardiol; 2004 Aug; 94(4):448-53. PubMed ID: 15325927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents.
    Veeraveedu PT; Palaniyandi SS; Yamaguchi K; Komai Y; Thandavarayan RA; Sukumaran V; Watanabe K
    Drug Discov Today; 2010 Oct; 15(19-20):826-41. PubMed ID: 20708094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disorders of body water regulation and the therapy--vasopressin antagonists].
    Ishikawa S; Saito T
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1654-9. PubMed ID: 9410978
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyponatremia and the use of vasopressin receptor antagonists in critically ill patients.
    Lehrich RW; Greenberg A
    J Intensive Care Med; 2012; 27(4):207-18. PubMed ID: 21571754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.